What LANXESS Bears Saw Before The Fall

LANXESS has had a busy year, from new tire additives like Vulkanox 4060 to shifting blocs of institutional investors filing voting-rights notices. None of that spared holders. Holding LANXESS over the past year would have meant a 37.8% loss, including dividends. If you had committed fresh capital in October 2025, the question now is whether the push into specialties and sustainability is sufficient to justify remaining invested.

A Narrative on Simply Wall St is one investor's written case for a company, with its growth, margin and multiple assumptions spelled out. Those assumptions imply an estimated Fair Value.

This theme extends beyond LANXESS. See which of 32 best rare earth metal stocks may still merit a closer look.

The Argument Investors Had To Settle On LANXESS

The shares cost €20.14 at the start of the period, and anyone looking at LANXESS then had to pick between two very different stories.

The bullish narrative put Fair Value at €26.79, which is 33% above the start price. It relied on a 1.4% annual revenue growth assumption and a future profit margin of 0.2%, tied to portfolio shifts toward specialty additives and consumer protection.

The bearish view saw Fair Value at €17, which is 16% below the start price. It focused on rising regulatory costs and tougher Asian competition combined with an assumed 0.1% annual revenue decline risk.

What The Results Changed For LANXESS

Vulkanox 4060, LANXESS's new 6PPD alternative for tires, gave the bullish story real product backing because it aligns with the earlier sustainability and specialty-chemicals pitch. The Q2 2026 figures pulled in the other direction. Revenue reached €1,561m, yet the group still reported a loss of €53m and a net margin that moved further into the red to -3.4%. The evidence cut both ways.

The key lesson is simple. When a thesis leans on better margins, treat every new eco-focused product win as a plus, but check future filings to see whether net margin and absolute profit are actually turning.

What LANXESS’s Lower Price Now Asks You To Believe

LANXESS trades at €12.83 today after a 37.8% loss over the past year, and the selected Narrative’s Fair Value sits above that level based on its own modelling rather than any proven outcome.

The Narrative hangs on LANXESS shifting toward higher margin, sustainability focused areas and squeezing more cash from a leaner network, so a buyer now would need to judge that these moves truly translate into more durable, recurring earnings.

"Strategic portfolio optimization, including the divestiture of the urethane business, accelerated closure of high-cost, high-CO2 assets, and network consolidation, positions LANXESS to allocate capital toward higher-margin, resilient segments (e.g., specialty additives, consumer protection), which is likely to support margin expansion and more recurring earnings over time."

Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there

Before The Next Story Makes Headlines

The next headline does not have to be where your research begins. Go straight to the companies and see whether a contrarian opportunity could be taking shape.

• Company 1 - 27% below our estimate - builds chip and software hooks where data must be moved, secured and managed.
• Company 2 - 25% below our estimate - focuses on injectable treatments that reshape obesity and diabetes care for high-demand patients.
• Company 3 - 31% below our estimate - expands dealer reach, showrooms and ecommerce to pull customers from fragmented mattress sellers.

Three companies from the same screener. Open every one of the 197 undervalued companies on it →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com